Abstract
Substances are said to undergo an enterohepatic circulation (EHC) when they are excreted into the bile, pass into the lumen of the intestine, are reabsorbed and then return to the liver via the circulation. Many endogenous and exogenous substances can undergo an EHC. Among the endogenous substances are the bile salts, the biliary lipids and biliary phospholipids; the degree of reabsorbability varies considerably for each of these types of substances. Other endogenous substances include estrone and estriol (Sandberg et al., 1967), folic acid (Baker et al., 1965; Herbert, 1965), vitamin B12 (Grasbeck et al., 1958), and urobilinogen (Lester et al., 1965). Ibrahim and Watson (1968) demonstrated that an EHC exists for protoporphyrin in man. The oral administration of cholestyramine, an anionic exchange resin, improves the clinical condition of patients suffering from porphyria cutanea tarda (Stathers, 1966) or from erythropoietic protoporphyria (Lischner, 1966) apparently by interrupting the EHC for the porphyrins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ambre, J.J., Fischer, L.J.: Glutethimide intoxication: Plasma levels of glutethimide and a metabolite in humans, dogs and rats. Res. Comm. chem. Path. Pharmacol. 4, 307–326 (1972).
Arai, K., Golab, T., Layne, D.S., Prncus, G.: Metabolic fate of orally administered H8-norethynodrel in rabbits. Endocrinology 71, 639–648 (1962).
Baker, S. J., Kumar, S., Swaminathan, S. P.: Excretion of folic acid in bile. Lancet 1965 I, 685.
Baselt, R.C., Casarett, L. J.: Biliary and urinary elimination of methadone and its metabolites in the rat. Biochem. Pharmacol. 21, 2705–2712 (1972).
Becker, B. A., Hindman, K.L., Gibson, J.E.: Enhanced mortality of selected nervous system depressants in hypoexcretory mice. J. pharm. Sci. 57, 1010–1012 (1968).
Bergstrom, S.: Metabolism of bile acids. Fed. Proc. 21, 28–32 (Suppl. No. II) (1962).
Berthelot, P., Erlinger, S., Dhumeaux, D., Preauz, A.-M.: Mechanism of phenobarbital-induced hypercholeresis in the rat. Amer. J. Physiol. 219, 809–813 (1970).
Borgstrom, G., Dahlqvist, A., Lundh, G., Sjovall, J.: Studies of intestinal digestion and absorption in the human. J. clin. Invest. 36, 1521–1536 (1957).
Bremer, J.: Species differences in the conjugation of free bile acids with taurine and glycine. Biochem. J. 63, 507–513 (1956).
Caldwell, J. H., Bush, C. A., Greenberger, N.J.: Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man. J. clin. Invest. 50, 2638–2644 (1971).
Caldwell, J.H., Dring, L.G., Williams, R. T.: Biliary excretion of amphetamine and methamphetamine in the rat. Biochem. J. 129, 25–29 (1972).
Caldwell, J. H., Greenberger, N.J.: Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication. J. clin. Invest. 50, 2626–2637 (1971).
Castle, M.C., Lage, G.L.: Enhanced excretion of digitoxin following spironolactone as it relates to the prevention of digitoxin toxicity. Res. Coram, chem. Path. Pharmacol. 5, 99–108 (1973).
Charytan, C.: The enterohepatic circulation in glutethimide intoxication. Clin. Pharmacol. Ther. 11, 816–820 (1970).
Clark, A.G., Fischer, L. J., Millburn, P., Smith, R.L., Williams, R.T.: The role of gut flora in the enterohepatic circulation of stilboestrol in the rat. Biochem. J. 112, 17P (1969).
Cook, D. A., Hagerman, L.M., Schneider, D.L.: Effect of dietary taurine on fecal bile salt excretion in rats and hamsters fed cholestyramine. Proc. Soc. exp. Biol. (N. Y.) 138, 830–834 (1971).
Cook, D. A., Hagerman, L.M., Schneider, D.L.: Preferential retention of taurine-conjugated bile salts by cholestyramine in the rat ileum. Proc. Soc. exp. Biol. (N. Y.) 139, 70–73 (1972).
Crew, M.C., Gala, E.L., Haynes, L.J., Dicarlo, F.J.: Biliary excretion and biotransformation of pentaerythritol trinitrate in rats. Biochem. Pharmacol. 20, 3077–3089 (1971).
Denbesten, L.: A technic for repeated bile collections from an intact enterohepatic circulation. Proc. Soc. exp. Biol. (N. Y.) 138, 208–209 (1971).
Dietschy, J.M.: Mechanisms for the intestinal absorption of bile acids. J. Lipid Res. 9, 297–309 (1968).
Dobbs, H.E., Hall, J. M.: Metabolism and biliary excretion of etorphine (M99-Reckitt) an extremely potent morphine-like drug. Proc. Europ. Soc. Study Drug Toxicity 10, 77–86 (1969).
Dobbs, H.E., Hall, J.M., Steiger, B.: Enterohepatic circulation of etorphine, a potent analgesic, in the rat. Proc. Europ. Soc. Study Drug Toxicity 11, 73–79 (1970).
Dougherty, J. E., Flanagan, W.J., Murphy, M.L., Bulloch, R. T., Dalrymphe, G.L., Beard, O.W., Perkins, W.H.: Tritiated digoxin. XIV. Enterohepatic circulation, absorption, and excretion studies in human volunteers. Circulation 42, 867–873 (1970).
Dowling, R.H.: The enterohepatic circulation. Gastroenterology 62, 122–140 (1972).
Dowling, R.H., Mack, E., Picott, J., Berger, J., Small, D.M.: Experimental model for the study of the enterohepatic circulation of bile in rhesus monkeys. J. Lab. clin. Med. 72, 169–176 (1968).
Eisenbrandt, L.L., Adler, T.K., Elliott, H.W., Abdou, I.A.: The role of the gastrointestinal tract in the excretion of C14-labeled methadone by rats. J. Pharmacol, exp. Ther. 98, 200–205 (1950).
Eriksson, H.: Absorption and enterohepatic circulation of neutral steroids in the rat. Europ. J. Biochem. 19, 416–423 (1971).
Eyssen, H., Evrard, E., Vanderhaeghe, H.: Cholesterol-lowering effects of N-methylated neomycin and basic antibiotics. J. Lab. clin. Med. 68, 753–768 (1966).
Figueroa, W.G., Thompson, J. H.: Biliary iron excretion in normal and ironloaded rats after desferoxamine and CaDTPA. Amer. J. Physiol. 215, 807–810 (1968).
Fischer, L.J., Kent, T.H., Weissinger, J.L.: Absorption of diethylstilbestrol and its glucuronide conjugate from the intestines of five- and twenty-five-day-old rats. J. Pharmacol. exp. Ther. 185, 163–170 (1973).
Fischer, L. J., Millburn, P.: Stilboestrol transport and glucuronide formation in everted sacs of rat intestine. J. Pharmacol, exp. Ther. 175, 267–275 (1970).
Fischer, L.J., Millburn, P., Smith, R.L., Williams, R.T.: The fate of [14C] stilboestrol in the rat. Biochem. J. 100, 69P (1966).
Fischer, L. J., Weissinger, J.L., Kent, T.H.: The role of intestinal β-glucuronidase in the absorption of diethylstilbestrol glucuronide in immature rats. Toxicol, appl. Pharmacol. 19, 396–397 (1971).
Eorman, D.T., Garvin, J.E., Forestner, J.E., Taylor, C.B.: Increased excretion of fecal bile acids by an oral hydrophilic colloid. Proc. Soc. exp. Biol. (N. Y.) 127, 1060–1063 (1968).
Gibson, J.E., Becker, B.A.: Demonstration of enhanced lethality of drugs in hypoexcretory animals. J. pharm. Sci. 56, 1503–1505 (1967).
Glasser, J.E., Weiner, I. M., Lack, L.: Comparative physiology of intestinal taurocholate transport. Amer. J. Physiol. 208, 359–362 (1965).
Glassman, J.M., Warren, G.H., Rosenman, S.B., Agersborg, H.P.K.: Pharmacology and distribution of WY-3277 (nafcillin): 6-(2-ethoxyl-l-naphthamido) penicillanic acid. Toxicol. appl. Pharmacol. 6, 220–231 (1964).
Goldstein, J. A., Taurog, A.: Enhanced biliary excretion of thyroxine glucuronide in rats pretreated with benzpyrene. Biochem. Pharmacol. 17, 1049–1065 (1968).
Grasbeck, R., Nyberg, W., Reizenstein, P.: Biliary and fecal vitamin B12 excretion in man. An isotope study. Proc. Soc. exp. Biol. (N. Y.) 97, 780–784 (1958).
Greenberger, N.J., Thomas, F.B.: Biliary excretion of sH-digitoxin: Modification by bile salts and phenobarbital. J. Lab. clin. Med. 81, 241–251 (1973).
Hanahan, D.J., Daskalakis, E.G., Edwards, T., Dauben, H.J., Jr.: The metabolic pattern of C14-diethylstilbestrol. Endocrinology 53, 163–170 (1953).
Hardison, W.G.M., Apter, J.T.: Micellar theory of biliary cholesterol excretion. Amer. J. Physiol. 222, 61–67 (1972).
Hashim, S.A., Van Itallte, T. B.: Cholestyramine resin therapy for hypercholesteremia. J. Amer. med. Ass. 192, 289–293 (1965).
Herbert, V.: Excretion of folic acid in bile. Lancet 1965 I, 913.
Hofmann, A. F.: Clinical implications of physicochemical studies on bile salts. Gastroenterology 48, 484–494 (1965).
Hofmann, A.P.: The syndrome of ileal disease and the broken enterohepatic circulation: Cholerheic enteropathy. Gastroenterology 52, 752–757 (1967).
Hofmann, A.F., Small, D.M.: Detergent properties of bile salts: correlation with physiological function. Ann. Rev. Med. 18, 333–376 (1967).
Holder, G.M., Ryan, A. J., Watson, T.R., Wiebe, L.L.: The biliary metabolism of butylated hydroxytoluene (3, 5-di-t-butyl-4-hydroxytoluene) and its derivatives in the rat. J. Pharm. Pharmacol. 22, 832–838 (1970).
Hucker, H.B., Zacchei, A.G., Cox, S.V., Brodie, D.A., Cantwell, N.H.R.: Studies on the absorption, distribution and excretion of indomethacin in various species. J. Pharmacol. exp. Ther. 153, 237–249 (1966).
Huff, J. W., Gilfillan, J. L., Hunt, V. M.: Effect of cholestyramine, a bile acid binding polymer on plasma cholesterol and iecal bile acid excretion in the rat. Proc. Soc. exp. Biol. (N. Y.) 114, 352–355 (1963).
Ibrahim, G. W., Watson, C. J.: Enterohepatic circulation and conversion of protoporphyrin to bile pigment in man. Proc. Soc. exp. Biol. (N. Y.) 127, 890–895 (1968).
Jansen, G.R., Zanetti, M.E.: Cholestyramine in dogs. J. pharm. Sci. 54, 863–867 (1965).
Katzung, B.G., Meyers, F.H.: Excretion of radioactive digitoxin by the dog. J. Pharmacol. exp. Ther. 149, 257–262 (1965).
Keberle, H., Hoffmann, K., Bernhard, K.: The metabolism of glutethimide (Doriden). Experientia (Basel) 18, 105–111 (1962).
Klaassen, C.D.: Biliary flow after microsomal enzyme induction. J. Pharmacol, exp. Ther. 168, 218–223 (1969).
Klaassen, C.D.: Effects of phénobarbital on the plasma disappearance and biliary excretion of drugs in rats. J. Pharmacol, exp. Ther. 175, 289–300 (1970a).
Klaassen, C.D.: Plasma disappearance and biliary excretion of sulfobromophthalein and phenol-3, 6-dibromophthalein disulfonate after microsomal enzyme induction. Biochem. Pharmacol. 19, 1241–1249 (1970b).
Klaassen, C.D.: Studies on the increased biliary flow produced by phénobarbital in rats. J. Pharmacol, exp. Ther. 176, 743–751 (1971a).
Klaassen, C.D.: Does bile acid secretion determine canalicular bile production in rats ? Amer. J. Physiol. 220, 667–673 (1971 b).
Klaassen, C.D.: Comparison of the toxicity of chemicals in newborn rats to bile duct-ligated and sham-operated rats and mice. Toxicol, appl. Pharmacol. 24, 37–44 (1973).
Klaassen, C.D., Plaa, G.L.: Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance. J. Pharmacol, exp. Ther. 161, 361–366 (1968).
Lack, L., Weiner, I.M.: In vitro absorption of bile salts by small intestine of rats and guinea pigs. Amer. J. Physiol. 200, 313–317 (1961).
Lack, L., Weiner, I.M.: Intestinal bile salt transport: structure-activity relationships and other properties. Amer. J. Physiol. 210, 1142–1152 (1966).
Lack, L., Weiner, I.M.: Role of the intestine during the enterohepatic circulation of bile salts. Gastroenterology 52, 282–287 (1967).
Ladomery, L.G., Ryan, A. J., Wright, S.E.: The excretion of [14C] butylated hydroxytoluene in the rat. J. Pharm. Pharmacol. 19, 383–387 (1967).
Layne, D.S., Golab, T., Arai, K., Pincus, G.: The metabolic fate of orally administered 3H-norethynodrel and 3H-norethindrone in humans. Biochem. Pharmacol. 12, 905–911 (1963).
Lester, R., Schumer, W., Schmid, R.: Intestinal absorption of bile pigments. IV. Urobilinogen absorption in man. New Engl. J. Med. 272, 939–943 (1965).
Levine, W.G.: Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide. Life Sci. 10, 727–735 (1971).
Levine, W.G., Millburn, P., Smith, R.L., Williams, R.T.: The role of the hepatic endoplasmic reticulum in the biliary excretion of foreign compounds by the rat. The effect of phenobarbitone and SKF 525-A (diacetylaminoethyl diphenylpropylacetate). Biochem. Pharmacol. 19, 235–244 (1970).
Lindstedt, S.: The turnover of cholic acid in man. Bile acids and steroids, 51. Acta physiol. Scand. 40, 1–9 (1957).
Lischner, H.W.: Cholestyramine and porphyrin-binding. Lancet 1966II, 1079–1080.
March, C.H., Elliott, H. W.: Distribution and excretion of radioactivity after administration of morphine-N-methyl C14 to rats. Proc. Soc. exp. Biol. (N. Y.) 86, 494–497 (1954).
Moore, R.B., Crane, C.A., Frantz, I.D., Jr.: Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4–14C and its degradation products in a hyper-cholesterolemic patient. J. clin. Invest. 47, 1664–1671 (1968).
Norman, A., Sjovall, J.: On the transformation and enterohepatic circulation of cholic acid in the rat: Bile acids and steroids 68. J. biol. Chem. 233, 872–885 (1958).
Okita, G.T.: Species difference in duration of action of cardiac glycosides. Fed. Proc. 26, 1125–1130 (1967).
Okita, G.T., Talso, P.J., Curry, J.H., Jr., Smith, F.D., Jr., Geilling, E.M.K.: Metabolic fate of radioactive digitoxin in human subjects. J. Pharmacol, exp. Ther. 115, 371–379 (1955).
Papapetrou, P.D., Marchand, B., Gavras, H., Alexander, W.D.: Biliary excretion of 35S-labelled propylthiouracil, methimazole and Carbimazole in untreated and pentobarbitone pretreated rats. Biochem. Pharmacol. 21, 363–377 (1972).
Plaa, G.L.: Biliary and other routes of excretion of drugs. In: Ladu, B.N., Mandel, H.G., Way, E.L. (Eds.): Fundamentals of drug metabolism and drug disposition, pp. 131–145. Baltimore: Williams and Wilkins 1971.
Playoust, M.R., Isselbacher, K.J.: Studies on the transport and metabolism of conjugated bile salts by intestinal mucosa. J. clin. Invest. 43, 467–476 (1964).
Powell, R.C., Nunes, W.T., Harding, R.S., Vacca, J.B.: The influence of non-absorbable antibiotics on serum lipids and the excretion of neutral sterols and bile acids. Amer. J. clin. Nutr. 11, 156–168 (1962).
Redinger, R.N., Small, D.M.: Primate biliary physiology. VIII. The effect of phenobarbital upon bile salt synthesis and pool size, biliary lipid secretion, and bile composition. J. clin. Invest. 52, 161–172 (1973).
Roberts, R. J., Plaa, G.L.: Effect of phenobarbital on the excretion of an exogenous bilirubin load. Biochem. Pharmacol. 16, 827–835 (1967).
Roe, D. A.: The clinical and biochemical significance of taurine excretion in psoriasis. J. invest. Derm. 39, 537–542 (1962).
Samuel, P., Steiner, A.: Effect of neomycin on serum cholesterol level of man. Proc. Soc. exp. Biol. (N. Y.) 100, 193–195 (1959).
Samuel, P., Waithe, W.I.: Reduction of serum cholesterol concentrations by neomycin, para-aminosalicylic acid and other antibacterial drugs in man. Circulation 24, 578–591 (1961).
Sandberg, A.A., Kirdani, R.Y., Back, N., Weyman, P., Slaunwhite, W.R., Jr.: Biliary excretion and enterohepatic circulation of estrone and estriol in rodents. Amer. J. Physiol. 213, 1138–1142 (1967).
Small, D.M.: Physiochemical studies of cholesterol gallstone formation. Gastroenterology 52, 607–610 (1967).
Smith, D.S., Peterson, R.E., Fujlmoto, J.M.: Species differences in the biliary excretion of morphine, morphine-3-glucuronide and morphine-3-ethereal sulfate in the cat and rat. Biochem. Pharmacol. 22, 485–492 (1973).
Smith, R.L.: Excretion of drugs in bile. In: Brodle, B.B., Gillette, J.R., Mitchell, J.R. (Eds.): Concepts of biochemical pharmacology, Handbook of experimental pharmacology, Vol. 28, Part 1, pp. 354–389. Berlin-Heidelberg-New York: Springer 1971.
Stathers, G.M.: Porphyrin-binding effect of cholestyramine. Results of in-vitro and in-vivo studies. Lancet 1966 II, 780–783.
Steiner, A., Howard, E., Akgun, S.: Effect of antibiotics on the serum cholesterol concentration of patients with atherosclerosis. Circulation 24, 729–735 (1961).
Stewart, G.T., Harrison, P.M.: Excretion and re-excretion of a broad spectrum penicillin in bile. Brit. J. Pharmacol. 17, 414–419 (1961).
Stowe, C.M., Plaa, G.L.: Extrarenal excretion of drugs and chemicals. Ann. Rev. Pharmacol. 8, 337–356 (1968).
Thompson, R.Q., Sturtevant, M., Bird, O.D., Glazko, A.J.: The effect of metabolites of chloramphenicol (Chloromycetin) on the thyroid of the rat. Endocrinology 55, 665–681 (1954).
Van Loon, E. J., Flanagan, T.L., Novice, W. J., Maass, A.R.: Hepatic secretion and urinary excretion of three S35-labeled phenothiazines in the dog. J. pharm. Sci. 53, 1211–1213 (1964).
Way, E.L., Adler, T.K.: The pharmacologic implications of the fate of morphine and its surrogates. Pharmacol. Rev. 12, 383–446 (1960).
Williams, R. T., Millburn, P., Smith, R.L.: The influence of enterohepatic circulation on toxicity of drugs. Ann. N. Y. Acad. Sci. 123, 110–124 (1965).
Winder, C.V., Kaump, D.H., Glazko, A.J., Holmes, E.L.: Pharmacology of the fenamates. Ann. phys. Med. (Supplement) 7–49 (1966).
Wood, P., Shioda, R., Estrich, D., Splitter, S.: The influence of oral cholestyramine on human bile composition. Clin. Res. 17, 162 (1969).
Woods, L. A.: Distribution and fate of morphine in non-tolerant and tolerant dogs and rats. J. Pharmacol, exp. Ther. 112, 158–175 (1954).
Wyngaarden, J.B., Petersen, R.E., Wolf, A. R.: Physiologic disposition of radiometabolites of hydrocortisone-4-C14 in the rat and guinea-pig. J. biol. Chem. 212, 963–972 (1955).
Yesaer, D.W., Callahan, M., Remington, L., Kensler, C. J.: Role of the enterohepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys. Biochem. Pharmacol. 19, 1579–1590 (1970).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Plaa, G.L. (1975). The Enterohepatic Circulation. In: Gillette, J.R., Mitchell, J.R. (eds) Concepts in Biochemical Pharmacology. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 28 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46314-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-46314-3_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46316-7
Online ISBN: 978-3-642-46314-3
eBook Packages: Springer Book Archive